Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.
Article
CAS
PubMed
Google Scholar
Peterson RC. Mild cognitive impairment. N Engl J Med. 2011;364:2227–34.
Article
Google Scholar
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2014;256:240–6.
Article
Google Scholar
Espinosa A, Alegret M, Valero S, Vinyes-Junqué G, Hernández I, Mauleón A, et al. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis. 2013;34:769–80.
PubMed
Google Scholar
Tatsuoka C, Tseng H, Jaeger J, Varadi F, Smith MA, Yamada T, et al. Modeling the heterogeneity in risk of progression to Alzheimer’s disease across cognitive profiles in mild cognitive impairment. Alzheimers Res Ther. 2013;5:14.
Article
PubMed Central
PubMed
Google Scholar
Han JW, Kim TH, Lee SB, Park JH, Lee JJ, Huh Y, et al. Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimers Dement. 2012;8:553–9.
Article
PubMed
Google Scholar
Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia: meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252–65.
Article
CAS
PubMed
Google Scholar
Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–16.
Article
PubMed Central
CAS
PubMed
Google Scholar
Clerici F, Del-sole A, Chiti A, Maggiore L, Lecchi M, Pomati S, et al. Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis. Q J Nucl Med Mol Imaging. 2009;53:646–57.
CAS
PubMed
Google Scholar
Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, et al. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol. 2008;255:1344–53.
Article
PubMed
Google Scholar
Pa J, Boxer A, Chao LL, Gazzaley A, Freeman K, Kramer J, et al. Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol. 2009;65:414–23.
Article
PubMed Central
PubMed
Google Scholar
He J, Farias S, Martinez O, Reed B, Mungas D, Decarli C. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol. 2009;66:1393–9.
Article
PubMed Central
PubMed
Google Scholar
Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447–55
Clark L, Delano-Wood L, Libon D, McDonald C, Nation D, Bangen KJ, et al. Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes? J Int Neuropsychol Soc. 2013;19:635–45.
Article
PubMed Central
PubMed
Google Scholar
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Article
CAS
PubMed
Google Scholar
Brucki SMD, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr. 2003;61:777–81.
Article
PubMed
Google Scholar
Nitrini R, Caramelli P, Porto CS, Charchat-Fichman H, Formigoni AP, Carthery-Goulart, et al. Brief cognitive battery in the diagnosis of mild Alzheimer’s disease in subjects with medium and high levels of education. Dement Neuropsychol. 2007;1:32–6.
Google Scholar
Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, et al. Clock drawing in Alzheimer’s disease: a novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725–9.
Article
CAS
PubMed
Google Scholar
Takada LT, Caramelli P, Fichman HC, Porto CS, Bahia VS, Anghinah R, et al. Comparison between two tests of delayed recall for the diagnosis of dementia. Arq Neuropsiquiatr. 2006;64:35–40.
Article
PubMed
Google Scholar
de Gobbi Porto FH, Spíndola L, de Oliveira MO, Vale PH F d, Orsini M, Nitrini R. A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints. Neurol Int. 2013;5:e16.
Article
PubMed Central
PubMed
Google Scholar
Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165–73.
Article
Google Scholar
Pachana NA, Byrne GJ, Siddle H, Koloski N, Harley E, Arnold E. Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr. 2007;19:103–14.
Article
PubMed
Google Scholar
Pfeffer RI, Kurosaki TT, Harrah Jr CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323–9.
Article
CAS
PubMed
Google Scholar
Fazekas F, Chawluk JB, Alavi A, Hurtig WI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149:351–6.
Article
CAS
PubMed
Google Scholar
Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage. 1999;9:63–80.
Article
CAS
PubMed
Google Scholar
Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000;10:120–31.
Article
CAS
PubMed
Google Scholar
Lancaster JL, Rainey LH, Summerlin JL, Freitas CS, Fox PT, Evans AC, et al. Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp. 1997;5:238–42.
Article
PubMed Central
CAS
PubMed
Google Scholar
Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging. 2003;30:1104–13.
Article
PubMed
Google Scholar
Brett M, Anton J, Valabregue R, Poline J. Region of interest analysis using an SPM toolbox [abstract] Presented at the 8th International Conference on Functional Mapping of the Human Brain, Sendai, Japan. Available on CD-ROM in NeuroImage, 2002;16:2.
Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, et al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73:1193–9.
Article
PubMed Central
CAS
PubMed
Google Scholar
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011;32:1207–18.
Article
PubMed Central
PubMed
Google Scholar
Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E. Education and occupation as proxies for reserve in aMCI converters and AD FDG-PET evidence. Neurology. 2008;71:1342–9.
Article
CAS
PubMed
Google Scholar
Morbelli S, Perneczky R, Drzezga A, Frisoni G, Caroli A, Berckel B, et al. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med. 2013;54:894–902.
Article
CAS
PubMed
Google Scholar
Buckner R. The serendipitous discovery of the brain’s default network. Neuroimage. 2012;62:1137–45.
Article
PubMed
Google Scholar
Leech R, Sharp D. The role of the posterior cingulate cortex in cognition and disease. Brain. 2014;137:12–32.
Article
PubMed Central
PubMed
Google Scholar
Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709–17.
Article
CAS
PubMed
Google Scholar
Fjell A, McEvoy L, Holland D, Dale A, Walhovd K. Alzheimer’s disease neuroimaging initiative. What is normal in normal aging? Effects of aging, amyloid and Alzheimer’s disease on the cerebral cortex and the hippocampus. Prog Neurobiol. 2014;117:20–40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry. 2007;78:240–7.
Article
PubMed Central
CAS
PubMed
Google Scholar
Szczepanski S, Knight R. Insights into human behavior from lesions to the prefrontal cortex. Neuron. 2014;83:1002–18.
Article
PubMed Central
CAS
PubMed
Google Scholar
Li W, Qin W, Liu H, Fan L, Wang J, Jiang T, et al. Subregions of the human superior frontal gyrus and their connections. Neuroimage. 2013;78:46–58.
Article
PubMed
Google Scholar
Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61:1545–50.
Article
PubMed
Google Scholar
Murray ME, Senjem ML, Petersen RC, Hollman JH, Preboske GM, Weigand SD, et al. Functional impact of white matter hyperintensities in cognitively normal elderly. Arch Neurol. 2010;67:1379–85.
Article
PubMed Central
PubMed
Google Scholar
Gouw A, Seewann A, Flier W, Barkhof F, Rozemuller A, Scheltens P, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatr. 2011;82:126–35.
Article
PubMed
Google Scholar
Hedden T, Oh H, Younger AP, Patel TA. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology. 2013;80:1341–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Haldenwanger A, Eling P, Kastrup A, Hildebrandt H. Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non amnesic MCI, and Alzheimer’s disease. J Alzheimers Dis. 2010;22:971–80.
PubMed
Google Scholar
Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5:228–34.
Article
CAS
PubMed
Google Scholar
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385–93.
Article
CAS
PubMed
Google Scholar
Alexopoulos P, Guo LH, Jiang M, Bujo H, Grimmer T, Förster S, et al. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature. J Alzheimers Dis. 2013;36:401–8.
CAS
PubMed
Google Scholar
Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease. Brain. 2007;130:2837–44.
Article
PubMed
Google Scholar
Jack Jr CR, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, et al. Amyloid-first and neurodegeneration first profiles characterize incident amyloid PET positivity. Neurology. 2013;81:1732–40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jack Jr CR, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, et al. Rates of b-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 2014;82:1605–12.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, et al. Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. Neuroimage Clin. 2015;7:187–94.
Article
PubMed Central
PubMed
Google Scholar
Rabinovici GD, Stephens ML, Possin KL. Executive dysfunction. Continuum (Minneap Minn). 2015;21:646–59.
PubMed
Google Scholar
Woodward M, Brodaty H, Boundy K, Ames D, Blanch G, Balshaw R. Does executive impairment define a frontal variant of Alzheimer's disease? Int Psychogeriatr. 2010;22:1280–90.
Article
PubMed
Google Scholar